Grifols | GRFS - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Alaunos Therapeutics USD 1.94M 941K 2025-09
Arca Biopharma USD 91.25M 25.86M 2025-09
aTyr Pharma USD 6.15M 11.07M 2025-09
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Capricor Therapeutics USD 287.85M 268.34M 2025-12
Cara Therapeutics USD 20.65M 13.57M 2025-06
Esperion Therapeutics USD 92.45M 6.39M 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Immunic USD 35.13M 20.18M 2025-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
TherapeuticsMD 523K 89K 2024-06